Bladder Volume Manometer Catheter Market – Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Product (Indwelling Catheters, Intermittent Catheters, External Catheters), By Application (Urinary Incontinence, Benign Prostatic Hyperplasia, Surgery, Others), By End User (Hospitals & Clinics, Ambulatory Centers, Others), By Region & Competition, 2021-2031F

Forecast Period	2027-2031
Market Size (2025)	USD 616.48 MIllion
CAGR (2026-2031)	5.31%
Fastest Growing Segment	Intermittent Catheters
Largest Market	North America
Market Size (2031)	USD 840.89 MIllion

Market Overview

The Global Bladder Volume Manometer Catheter Market will grow from USD 616.48 MIllion in 2025 to USD 840.89 MIllion by 2031 at a 5.31% CAGR. A bladder volume manometer catheter is a specialized medical device designed to measure intraabdominal pressure via the bladder, facilitating the precise diagnosis of conditions such as intraabdominal hypertension. These devices provide essential data for critical care management and serve as a reliable alternative to inaccurate clinical estimation methods. The market is primarily driven by the rising number of intensive care admissions and the increasing necessity to prevent organ failure associated with elevated abdominal pressure. Furthermore, the growing preference for minimally invasive monitoring solutions in trauma centers significantly bolsters the demand for these integrated catheter systems.

However, the market encounters a significant impediment regarding the inconsistent adoption of standardized monitoring protocols among medical professionals. Many facilities fail to utilize these specialized catheters due to a lack of awareness or training regarding pressure management standards. This challenge is substantial and clearly reflected in recent industry data. According to the World Society of the Abdominal Compartment Syndrome, in 2024, only 41% of healthcare practitioners had formally incorporated established guidelines for intraabdominal pressure management into their daily clinical practice. Such limited adherence to diagnostic protocols directly constrains the potential expansion of the global market.

Key Market Drivers

Growing clinical focus on reducing Catheter-Associated Urinary Tract Infections (CAUTI) is a primary force propelling the adoption of advanced bladder volume manometer catheters. Healthcare facilities are increasingly prioritizing catheter systems that integrate precise volume monitoring and pressure management to minimize the risks of over-distension and subsequent infection. This shift towards value-based care and strict infection control protocols has led to a measurable improvement in patient outcomes. According to the Centers for Disease Control and Prevention, November 2024, in the '2023 National and State Healthcare-Associated Infections Progress Report', acute care hospitals in the United States achieved an 11% decrease in catheter-associated urinary tract infections between 2022 and 2023. This reduction underscores the market's pivot towards sophisticated devices that mitigate infection risks while providing essential diagnostic data.

Escalating prevalence of urinary incontinence and bladder dysfunction further amplifies the demand for reliable monitoring solutions across both critical and chronic care settings. As the global burden of bladder-related conditions rises, the necessity for accurate diagnostic tools to manage these complex cases becomes more acute. According to the National Association for Continence, September 2024, in a joint press release regarding a new public health initiative, urinary incontinence affects nearly 100 million women in the U.S. alone, highlighting the massive patient base requiring effective management strategies. This widening demographic of patients contributes directly to the commercial expansion of the sector. Reflecting this broader market momentum, Convatec Group Plc, March 2024, reported in their 'Annual Report and Accounts 2023' that their Continence Care division achieved an organic revenue growth of 6.5%, driven by strong demand for their urological product portfolio.

Download Free Sample Report

Key Market Challenges

The inconsistent adoption of standardized monitoring protocols represents a substantial barrier to the expansion of the Global Bladder Volume Manometer Catheter Market. Although these devices offer precision in measuring intra-abdominal pressure, many medical facilities have not integrated them into routine critical care due to a pervasive lack of awareness and insufficient training among staff. When healthcare professionals are unfamiliar with the necessity of objective pressure measurement, they often default to subjective clinical estimations, which are notoriously inaccurate. This reliance on outdated methods reduces the perceived urgency to invest in specialized manometer catheters, thereby stalling procurement rates and limiting market penetration in key regions.

Recent data underscores the severity of this educational gap within the medical community. According to the World Society of the Abdominal Compartment Syndrome, in 2024, only 59% of healthcare practitioners were aware of the current guidelines regarding intra-abdominal hypertension management. This statistic highlights a critical disconnect between available diagnostic technology and clinical practice. As long as a large segment of the target user base remains uninformed about the risks of unmonitored abdominal pressure, the demand for bladder volume manometer catheters will remain suppressed, directly hampering the potential revenue growth of the market.

Key Market Trends

The Shift Toward Continuous Intra-Abdominal Pressure Monitoring is fundamentally reshaping the market by replacing intermittent, manual measurements with automated, real-time data collection. Clinicians are increasingly moving away from static analog manometers, which provide only snapshots of patient health, favoring systems that offer dynamic analytics to detect intra-abdominal hypertension (IAH) earlier. This transition is supported by the capability of modern devices to integrate urine output and pressure readings into a single stream of diagnostic intelligence, thereby reducing the workload on critical care staff. The market traction for such automated solutions is evident in the expanding user base of specialized monitoring platforms. According to Accuryn Medical, February 2024, in the press release 'Accuryn Medical Announces Successful Completion of Restructuring', the company confirmed that its Accuryn Monitoring System, a leading continuous monitoring technology, has been used to treat nearly 70,000 patients to date, reflecting the growing clinical dependence on real-time physiological data.

The Development of Multi-Parameter Smart Catheters is another dominant trend, characterized by the convergence of volume measurement, pressure sensing, and temperature monitoring within a single device architecture. This trend is driven by the need for high-fidelity diagnostic tools in interventional urology that streamline patient management in complex surgical and acute care environments. Unlike traditional Foley catheters, these advanced systems allow for the comprehensive assessment of bladder function and urethral integrity without requiring multiple invasive instruments. This demand for sophisticated, integrated urological technologies is translating into sustained sectoral growth. According to Coloplast A/S, November 2024, in the 'Annual Report 2023/24', the company’s Interventional Urology business area achieved an organic revenue growth of 5% for the fiscal year, underscoring the market's steady pivot toward advanced interventional solutions.

Segmental Insights

Within the Global Bladder Volume Manometer Catheter Market, the Intermittent Catheters segment currently demonstrates the fastest growth trajectory driven by an increased emphasis on infection prevention. This expansion is largely influenced by clinical recommendations from institutions such as the Centers for Disease Control and Prevention, which advocate for minimizing the use of indwelling devices to decrease Catheter-Associated Urinary Tract Infections. As healthcare facilities prioritize protocols that reduce hospital-acquired conditions, the demand for intermittent solutions has risen substantially. Furthermore, the shift toward home-based care encourages the adoption of these single-use devices, supporting the segment's accelerated progress.

Regional Insights

North America currently holds the leading position in the Global Bladder Volume Manometer Catheter Market, supported by a well-established healthcare infrastructure and high patient awareness. This regional dominance is largely attributed to an increasing geriatric population and the associated rise in urological disorders, such as urinary incontinence and bladder dysfunction. Furthermore, favorable reimbursement policies for urological management in the United States significantly drive the clinical adoption of these specialized devices. The strict safety and efficacy standards enforced by the U.S. Food and Drug Administration (FDA) also ensure the availability of reliable products, sustaining consistent market growth.

Recent Developments

• In December 2025, Observe Medical ASA received a loan commitment of NOK 15 million from Innovation Norway to support the continued commercialization of its UnoMeter product range and the preparations for the launch of Sippi, a next-generation digital urine measurement system. Sippi is designed to automate the measurement of urine output and incorporates a proprietary technology to prevent biofilm formation, addressing a key challenge in catheter-based monitoring. This funding is intended to accelerate the market entry of the digital system, which complements the company's existing manual manometer catheters, and to support the broader adoption of its precision monitoring solutions in intensive care units.
• In February 2025, Bactiguard Holding AB confirmed in its year-end report that the transition of its BIP Foley catheter markets to Becton, Dickinson and Company (BD) was successfully executed during 2024. This strategic shift followed an exclusive global license agreement signed previously, which granted BD the rights to manufacture and sell Bactiguard-coated Foley catheters in markets excluding China. The collaboration allows BD, a major player in the urology and critical care sectors, to integrate Bactiguard's infection-prevention coating technology into its own extensive catheter portfolio. The report highlighted that the partnership aims to enhance patient safety by reducing the risk of device-related infections while allowing Bactiguard to focus on its licensing business model.
• In May 2024, Observe Medical ASA announced the early commercial launch of the UnoMeter Safeti Plus, a urine measurement system with a long-standing presence in the European market. This launch followed the company's acquisition of the UnoMeter brand from Convatec and represented a significant milestone in its strategy to re-establish the product's global availability. The UnoMeter Safeti Plus is part of a broader portfolio that includes the UnoMeter Abdo-Pressure, a specialized device for monitoring intra-abdominal pressure. The early release was facilitated by a successful collaboration between the company's product development team and its external manufacturing partners, positioning the firm to recapture market share in the hourly diuresis monitoring segment.
• In February 2024, Accuryn Medical, formerly known as Potrero Medical, announced the completion of its corporate restructuring and the expansion of its product portfolio. The company introduced ten new sizes of its sensing Foley catheter, designed to accommodate a broader range of patient anatomies and reduce the risks associated with catheter-associated urinary tract infections (CAUTI). This product expansion aims to enhance the capabilities of the Accuryn Monitoring System, which provides real-time, automated measurement of urine output and intra-abdominal pressure, critical parameters for managing patients with acute kidney injury. The development aligns with the company's focus on precision fluid management and predictive health analytics in critical care settings.

Key Market Players

• Ameco Medical Industries
• Medica Group PLC
• UroMed Inc
• Mednova Ltd
• Medtronic Private Limited
• Lilium Otsuka Co., Ltd.
• Hollister Incorporated
• Hamilton Co
• Hi-Tech Assembly Systems Inc
• Medax International Inc

By Product	By Application	By End User	By Region
Indwelling Catheters Intermittent Catheters External Catheters	Urinary Incontinence Benign Prostatic Hyperplasia Surgery Others	Hospitals & Clinics Ambulatory Centers Others	North America Europe Asia Pacific South America Middle East & Africa

Report Scope:

In this report, the Global Bladder Volume Manometer Catheter Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

• Bladder Volume Manometer Catheter Market , By Product:

• Indwelling Catheters
• Intermittent Catheters
• External Catheters

• Bladder Volume Manometer Catheter Market , By Application:

• Urinary Incontinence
• Benign Prostatic Hyperplasia
• Surgery
• Others

• Bladder Volume Manometer Catheter Market , By End User:

• Hospitals & Clinics
• Ambulatory Centers
• Others

• Bladder Volume Manometer Catheter Market , By Region:

• North America
• United States
• Canada
• Mexico
• Europe
• France
• United Kingdom
• Italy
• Germany
• Spain
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• South America
• Brazil
• Argentina
• Colombia
• Middle East & Africa
• South Africa
• Saudi Arabia
• UAE